Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind
Jessica Howell, Alexander J Thompson
Gastroenterology | W B SAUNDERS CO-ELSEVIER INC | Published : 2017
The authors disclose the following: A. J. Thompson is an Advisory board member for Gilead Sciences, Abbvie, Bristol-Myers Squibb (BMS), and Merck; a speaker for Gilead Sciences, Abbvie, Merck, BMS, Roche Diagnostics; and receives research/grant support (to institution) from Gilead, Abbvie. J. Howell discloses no conflicts.